Asbury Finally Finished the Hard Part. Now It Has to Prove the Bill Was Worth It.

Tekion is fully deployed and the FTC case is dismissed — but the leverage target just slipped a year, the buyback paused, and the stock sits 21% below its July peak.

ABG · Earnings Call · 2026-10-27

The milestone versus the tape

Daniel Clara opened his prepared remarks with the sentence a management team waits years to say: “Every active Asbury store is now operating on Tekion, our single modern technology platform.” — Daniel Clara, Chief Executive Officer · 2026-10-27 Forty-seven stores converted in the third quarter — the company's largest single-quarter lift — with the final ten done in October. Across 157 dealerships, the dealer-management-system transplant is over. Operational excellence is no longer a promise wrapped around a project; it is now just the operating job. The proof points management can actually show are narrow but real. The longest-tenured markets — Koons and Georgia, roughly 35 to 40 stores past the six-month threshold — grew customer-pay gross profit 7% while the total company same-store base was flat, and total fixed-ops gross profit 5% against a 2% decline company-wide. Repair orders per advisor rose 9%, gross profit per technician 9%, units per salesperson 4%. The catch, stated plainly: “it takes 6 months for the muscle memory to kick in” — Daniel Clara, Chief Executive Officer · 2026-10-27 — muscle memory is now a phrase Asbury has used for at least four straight quarters, and it remains the single biggest variable in the equity story. Because 47 of the conversions happened in the quarter just ended, the bulk of the benefit lands at the tail of Q1 and into Q2 of 2027, not before. The tape has already voted on the delay. ABG is flat over the last 90 trading days and 21.5% below its July peak of $248.26, with the whole-history drawdown at 36.2% from the January 2025 high of $305.86. A milestone quarter that leaves the stock unmoved is a market saying show me the P&L.

Two goalposts moved, quietly

The headline promise is that SG&A as a percentage of gross profit reaches the low 60s by the end of 2027, from 67.4% on an all-store basis this quarter. Michael Welch was unusually candid about the arithmetic: “half of that comes from gross profit growth, and the other half comes from you know, true SG&A saves.” — Michael D. Welch, Chief Financial Officer · 2026-10-27 That first half is the problem. Asbury's gross profit has been running essentially flat year-over-year, and gross margin has been pinned near 17% since 2024 — well off the 20.2% peak of 2022. Gross profit of $753M in the June quarter was up 0% year-over-year, and the $732M printed this quarter was likewise flat. The second moved goalpost is leverage, and this one is harder to explain away. In February, Welch said: “So our goal is still to get below three times by the end of the year.” — Michael Welch, Chief Financial Officer (CFO) · 2026-02-05 Nine months later the company is at 3.5x and the language has become “Our target of 3x remains a priority for us, and we plan to reach it by mid-2027.” — Michael D. Welch, Chief Financial Officer · 2026-10-27 That is roughly a twelve-month slip, and it was delivered without much fanfare. The arithmetic behind it shows up in coverage: interest coverage has fallen from 15.2x in 2021 to 4.7x today, as acquisition debt replaced cheap equity-funded growth. Interest coverage of 4.7x is down 24% year-over-year and 69% from its 2021 high. Capital allocation flipped with it. Asbury bought back $147M of stock in Q1 2026 and another $131M in Q2, leaning into a dislocated price — “as the share price continues to dislocate and get low levels at attractive prices for us. We took a view that we need to take advantage of that stock price.” — Michael Welch, Chief Financial Officer · 2026-04-28 This quarter there was no repurchase to speak of: leverage first, then buybacks, then tuck-in acquisitions last. Management spent its own cash buying the dip; the dip is still there, and the cash is now earmarked for the balance sheet. Repurchases peaked at $172M in 2024Q3; the 2026 first-half burst has given way to deleveraging.

The most interesting tell: Total Care Auto

Buried in the Q&A is the clearest signal that management believes its problem is presentation, not performance. TCA generated $5M of pretax income against $14M a year ago, and the noncash deferral cost $0.69 per share — adjusted EPS of $6.16 would have been $6.85 without it. So Clara and Welch are now openly considering structural separation, explicitly to clean up optics.

You have to evaluate, you know, keep it as is, grow it, through other channels outside our dealerships. Or, to your point, you know, flip it out to have it be an outside company. To kind of get rid of the accounting noise.
Michael D. Welch, Chief Financial Officer · 2026-10-27

That is a remarkable admission. TCA is a capital-free annuity that management says it loves — "love what it does for us, love the cash flow" — and the only stated reason to part with it is to remove accounting noise from the earnings line. The TCA deferral has now been a recurring top keyword for several quarters running; turning it into a structural event rather than an accounting one would be the single biggest re-rating lever available.

What actually changed in the business

Two things did move. First, used vehicles: after years of a deliberate doctrine of chasing volume being the wrong answer — repeated on nearly every call since 2025 — Asbury grew used retail volume 4.5% sequentially while raising GPU 10% to $1.78K, and guided to a year-over-year volume increase in Q4. Both levers moving together is the first evidence the strategy change announced in May is more than a slogan. Second, fixed operations disappointed, and the explanation is instructive rather than alarming: customer-pay revenue rose just 2%, gross profit flat, warranty down 1%. Clara's diagnosis was that advisors new to the platform discount to keep guests moving — "the path of least resistance." The Florida market, which crossed the six-month mark at quarter-end, was up 3% in fixed-ops gross profit for September; Koons was up 9%. The mechanism is visible, which makes the 2027 promise more credible than the 2026 number. And the regulatory cloud lifted. The FTC administrative proceeding against the company was dismissed in early October, and Clara was firm that “I do not expect doc fees to go down.” — Daniel Clara, Chief Executive Officer · 2026-10-27 Notably, doc fee appeared in the market-wide top-75 keyword list this quarter — an unusual cameo for a dealership-accounting term, suggesting the enforcement wave is being watched across the sector, not just here.

The setup

The bull case is now unusually clean in its logic: the DMS conversion is done, the FTC overhang is gone, the used-car pivot is working, and the stock trades at 7.3x earnings against a 13.4x peak in 2024, and 1.2x gross profit against 2.8x in 2021. Clara's own framing — current share price does not reflect the value visible in private dealership transactions, with over 80% of real estate owned — is a classic sum-of-parts argument. Price-to-net-income of 7.3x is down 45% from its 2024Q3 peak of 13.4x. The bear case is equally simple: the two things that would close that gap — leverage below 3x and SG&A in the low 60s — are both 2027 events, one of them just moved by a year, and the buyback that was supposed to monetize the dislocation has been switched off. Asbury did the hard work. The next four quarters are about whether the numbers arrive on the new schedule.